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Aminoglycoside antibiotics are “the drug of choice” for treating many bacterial infections,
but their administration results in hearing loss in up to one fourth of the patients who
receive them. Several biochemical pathways have been implicated in aminoglycoside
antibiotic ototoxicity; however, little is known about how hair cells respond to
aminoglycoside antibiotics at the transcriptome level. Here we have investigated the
genome-wide response to the aminoglycoside antibiotic gentamicin. Using organotypic
cultures of the perinatal organ of Corti, we performed RNA sequencing using cDNA
libraries obtained from FACS-purified hair cells. Within 3 h of gentamicin treatment,
the messenger RNA level of more than three thousand genes in hair cells changed
significantly. Bioinformatic analysis of these changes highlighted several known signal
transduction pathways, including the JNK pathway and the NF-κB pathway, in addition
to genes involved in the stress response, apoptosis, cell cycle control, and DNA
damage repair. In contrast, only 698 genes, mainly involved in cell cycle and metabolite
biosynthetic processes, were significantly affected in the non-hair cell population. The
gene expression profiles of hair cells in response to gentamicin share a considerable
similarity with those previously observed in gentamicin-induced nephrotoxicity. Our
findings suggest that previously observed early responses to gentamicin in hair cells in
specific signaling pathways are reflected in changes in gene expression. Additionally,
the observed changes in gene expression of cell cycle regulatory genes indicate a
disruption of the postmitotic state, which may suggest an alternate pathway regulating
gentamicin-induced apoptotic hair cell death. This work provides a more comprehensive
view of aminoglycoside antibiotic ototoxicity, and thus contributes to identifying potential
pathways or therapeutic targets to alleviate this important side effect of aminoglycoside
antibiotics.
Keywords: sensory hair cells, aminoglycoside antibiotics, gentamicin, ototoxicity, RNA sequencing, differential
gene expression
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Introduction
Ototoxicity is a well-known side effect limiting the use of
aminoglycoside antibiotics, with reported incidence of hearing
loss between 2% and 25% of treated patients (Huth et al., 2011).
Several biochemical mechanisms of aminoglycoside ototoxicity
have been investigated, including production of reactive oxygen
species (ROS) (Forge and Schacht, 2000), disruption of
intracellular calcium storage (Matsui et al., 2004), and inhibition
of cytoplasmic protein synthesis (Francis et al., 2013). Through
biochemical assays, some pathways have also been identified as
signaling pathways mediating aminoglycoside-induced hair cell
death, such as the pro-apoptotic JNK pathway (Ylikoski et al.,
2002) and the protective NF-κB pathway (Jiang et al., 2005).
Based on observations made in organ cultures, a timeline of
critical signaling events has been established. ROS production
is induced shortly after aminoglycoside administration; the JNK
pathway responds to drug treatment within 3 h; the intracellular
calcium level is increased dramatically at around 4 h; cytochrome
C is released into cytoplasm at around 12 h and apoptosis
execution steps occur at around 18 h (Matsui et al., 2004).
The methods utilizing low-throughput biochemical assays
have been instrumental in dissecting some of the sequelae of
antibiotic treatment of hair cells. However, cells are complex
systems that integrate input from multiple mechanisms and
respond by adjusting multiple pathways simultaneously. High-
throughput methods may help us gain a better understanding
of the ototoxicity associated with aminoglycosides by providing
a complex view of the response; among them, DNA microarray
and antibody array experiments have been performed to profile
the changes in the cochlea after ototoxic drug treatment at the
transcriptional level and the protein level, respectively (Nagy
et al., 2004; Jamesdaniel et al., 2008). However, whole cochlea
samples were used in those studies, which consisted largely of
many different non-hair cell populations in addition to hair cells,
and the heterogeneity of the samples limited the interpretation of
the results due to a low signal to noise ratio.
Here we have utilized RNA sequencing to investigate the
early gene expression changes in hair cells induced by the
aminoglycoside antibiotic gentamicin. Compared to microarray
analysis, RNA sequencing is more accurate for analyzing
expression levels, more informative for pathway analysis, and
more powerful in exploiting unannotated genes (Wang et al.,
2009). We made use of the Atoh1-GFP transgenic mice, whose
fluorescent reporter under the control of the Atoh1 enhancer
faithfully identifies hair cells (Lumpkin et al., 2003), to purify
GFP+ hair cells by fluorescence-activated cell sorting (FACS)
after a 3 h gentamicin treatment for a direct analysis of gene
expression changes by RNA sequencing. We chose the 3 h
time point because it was previously shown that signaling
pathways have initiated a response to the drug, but the cell
death process did not appear to be initiated (Matsui et al.,
2004). We present analyses of the gene changes associated with
several major pathways known to be dysregulated in response to
aminoglycoside antibiotics.
Genome wide, 3709 genes, including those involved in a
variety of pathways and cellular processes, were found to change
significantly in hair cells after gentamicin treatment. Genes
involved in the JNK pathway and the NF-κB pathway were
differentially expressed in gentamicin-treated hair cells, which
is consistent with previous findings that these pathways are
important for aminoglycoside ototoxicity (Ylikoski et al., 2002;
Jiang et al., 2005). Surprisingly, we did not observe a strong
stress response at the transcriptional level at this early time point.
Comparison of gentamicin-induced gene expression changes in
hair cells and data from other cell lines and tissues, revealed
a similarity between aminoglycoside-induced hair cell death
and neuronal cell death, as well as a resemblance between
aminoglycoside ototoxicity and nephrotoxicity. Additionally,
genes involved in the cell cycle and DNA damage repair were
also strongly affected by gentamicin at the transcriptional level,
indicating a gentamicin-induced disruption of the postmitotic
state, which may underlie an alternate pathway leading to hair
cell death. In contrast, significantly fewer genes (698 genes) with
altered expression after gentamicin treatment were present in the
non-hair cell population at this time. Interestingly, expression of
genes involved in cell cycle and metabolite biosynthesis pathways
were significantly affected in this population. Analyses of our
RNA sequencing data indicate that prior to severe oxidative
stress, multiple events, including previously implicated activation
of the JNK and the NF-κB pathways, and newly hypothesized
disruption of the postmitotic state, occur in hair cells in
response to aminoglycoside antibiotic treatment. Our work
provides a comprehensive view of aminoglycoside ototoxicity,
and our transcriptome data could be used to analyze other
potential signaling pathways or biological processes mediating
aminoglycoside-induced hair cell death which are not covered
here.
Materials and Methods
Organotypic Culture, Drug Treatment, and FACS
Sorting
Atoh1-GFP transgenic mice on CD-1 background (Lumpkin
et al., 2003; available in the Jackson Laboratory but in different
genomic background: B6.129S-Atoh1tm4.1Hzo/J) were used for
this study. All animal procedures and usage were approved
by the IACUC committee in House Research Institute. Inner
ears were collected from postnatal day 1 (P1) animals under
sterile conditions and then transferred into ice cold Ca2+- and
Mg2+-free PBS (Invitrogen), in which cochlea were further
dissected under the microscope (Chen et al., 2002). The cochleae
were mounted on polycarbonate membranes (13mm diameter,
1.0µm pore size, SPI supplies) floating on DMEM/F12 medium
(Invitrogen) supplemented with 1% N2 (Gibco) and 100 U/ml
penicillin (Sigma). Organ cultures were maintained under low
oxygen conditions (37◦C, 5% CO2 and 5% O2) overnight, and
treated with gentamicin the next day.
To trace the accumulation of gentamicin in hair cells, Texas
Red conjugated gentamicin (GTTR) was prepared as described
in the literature (Steyger et al., 2003). 4.4ml of gentamicin
sulfate (Sigma; 50mg/ml in K2CO3, pH 9) was mixed with
0.6ml succinimidyl ester of Texas Red (Invitrogen; 2mg/ml in
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dimethyl formamide), and then agitated overnight to produce
a mixture of gentamicin and GTTR with an approximate 300:1
molar ratio. This GTTR mixture solution was diluted 1:100 with
culture medium for treatment of organotypic cultures. After
30min incubation, organs were fixed with 4% paraformaldehyde,
cryosectioned and photographed by fluorescence microscopy.
To confirm the level of hair cell death induced by gentamicin,
organ cultures were treated with 0.5mM gentamicin for 3 h,
and then gentamicin was washed out and replaced with fresh
medium. GFP positive hair cells were photographed at 3 and 24 h
timepoints (Figure 1B).
To purify hair cells for RNAseq, organs were digested
with 0.05% Trypsin (Invitrogen) and 1mg/ml Collagenase
(Worthington) in PBS at 37◦C for 8min, then incubated with
10% FBS (Life Technologies) in PBS to stop enzymatic digestion.
To make single cell suspensions, organs were triturated with a
P200 pipette 300 times. The suspension was passed through a
cell strainer (40µm, BD Biosciences) before FACS purification.
GFP-positive hair cells, as well as the GFP-negative non-hair
cell population (non-hair cell cochlear epithelial cells included
Deiters’ cells, pillar cells, Hensen cells, cells in the GER, cells
in the LER, and other cells constituting surrounding tissues)
were purified on a BD FACS Aria II with a 100 µ nozzle. Cells
with low-levels of GFP were excluded by stringent gating during
FACS purification (Figure 1C). Quality control by FACS-resort,
and by immunofluorescence for a hair cell marker (MyosinVI),
indicated >95% purity. Sorted cells were collected directly into
RNA lysis buffer (Zymo). At least 50,000 cells were collected
for each sample, and three replicates were prepared for each
condition.
RNA Sequencing, Reads Alignment, PCA and
Differential Gene Expression
RNA was extracted from samples using the Zymo Quick-RNA
Microprep kit, and then processed for library construction, using
the Illumina True-Seq mRNA-seq kit. Six samples were bar-
coded, combined into one lane, and sequenced by Illumina Hi-
Seq 2000 for single-end 50 cycles (50 bp reads). More than
30 million reads were obtained for each replicate. The reads
were trimmed on both ends (quality score ≥25) and aligned
against the mouse genome assembly mm10 using TopHat 2
in PartekFlow (Partek Inc.). Normalized read score for each
gene was calculated considering total read numbers and gene
length (reads per kilobase of transcript per million reads mapped,
RPKM). Principal component analysis (PCA) was conducted in
PartekFlow based on normalized read numbers for individual
genes in each replicate. Differential gene expression was assessed
by the embedded gene specific analysis (GSA) module in
PartekFlow.
RNA sequence data was deposited into NCBI GEO database
(GSE66775).
IPA Analysis
Differential gene expression datasets, including gene symbols,
fold changes, p-values and total numbers of raw reads, were
prepared for Ingenuity pathway analysis software (IPA, Version
21901358, Qiagen Inc.). The gene expression dataset from
untreated and gentamicin-treated hair cells, and from untreated
and treated non-hair cell samples, were analyzed by the IPA
software. A filter of p-value less than 0.01, fold change greater
than 1.2 (or less than −1.2), and total number of raw reads
greater than 100 was applied, and core pathway analysis was
conducted for each dataset. Canonical pathway analysis, diseases
and function analysis, upstream regulator analysis, and network
analysis were included in the core analysis with default settings.
Q-PCR Validation
The cDNA libraries for Q-PCR were made by qScript reverse
transcriptase supermix (Quanta Biosciences) using RNA
extracted from FACS purified cells as template. Rpl19 was used as
internal control for normalization. For validation purpose, four
independent biological replicates were collected and analyzed
by Q-PCR. Genes were chosen arbitrarily among the list of
gentamicin-induced genes in hair cells. SYBR-Green (Applied
Biosystems) was used to detect amplified double strand DNA
on ViiA 7 machine (Applied Biosystems). Primer pairs used for
Q-PCR were listed below. Rpl19 forward 5′-GGTCTGGTTGGA
TCCCAATG-3′, reverse 5′-CCCGGGAATGGACAGTCA-3′.
Atf2 forward 5′-CCGTTGCTATTCCTGCATCAA-3′, reverse 5′-
TTGCTTCTGACTGGACTGGTT-3′. Mapk8 forward 5′-AGC
AGAAGCAAACGTGACAAC-3′, reverse 5′-GCTGCACACACT
ATTCCTTGAG-3′. Jun forward 5′-CCTTCTACGACGATG
CCCTC-3′, reverse 5′-GGTTCAAGGTCATGCTCTGTTT-3′.
Nfkb1 forward 5′-ATGGCAGACGATGATCCCTAC-3′, reverse
5′-TGTTGACAGTGGTATTTCTGGTG-3′. Nfkbib forward
5′-GCGGATGCCGATGAATGGT-3′, reverse 5′-TGACGTAGC
CAAAGACTAAGGG-3′. Chuk forward 5′-GTCAGGACCGTG
TTCTCAAGG-3′, reverse 5′-GCTTCTTTGATGTTACTGAGG
GC-3′. Gadd45g forward 5′-GGGAAAGCACTGCACGAACT-
3′, reverse 5′-AGCACGCAAAAGGTCACATTG-3′. Klf11
forward 5′-CATGGACATTTGTGAGTCGATCC-3′, reverse
5′-CCTTTGGTAGATCAGGTGCAG-3′. Ddit3 forward 5′-CTG
GAAGCCTGGTATGAGGAT-3′, reverse 5′-CAGGGTCAAGAG
TAGTGAAGGT-3′. Bnip1 forward 5′-AGGCTATGCAGACT
CTAGTCAG-3′, reverse 5′-CAGTTCTCGGCGGTTGTACT-3′.
Casp3 forward 5′-ATGGAGAACAACAAAACCTCAGT-3′,
reverse 5′-TTGCTCCCATGTATGGTCTTTAC-3′. Ccar1
forward 5′-AGATGAGTATGACCCAATGGAGG-3′, reverse
5′-CCTTGCAGTACCGGCTGAC-3′. Ccnb2 forward 5′-GCC
AAGAGCCATGTGACTATC-3′, reverse 5′-CAGAGCTGGTAC
TTTGGTGTTC-3′. Ccne2 forward 5′-ATGTCAAGACGCAGC
CGTTTA-3′, reverse 5′-GCTGATTCCTCCAGACAGTACA-3′.
Ercc8 forward 5′-GAGGAAGATGAAGCTATGGAA-3′, reverse
5′-CTTCAGGGGTTTCTCTTTGTC-3′. Rad52 forward 5′-CTT
TGTTGGTGGGAAGTCTGT-3′, reverse 5′-CGGCTGCTAATG
TACTCTGGAC-3′. Apex2 forward 5′-GGATGGATGGCTTGC
TCAGTA-3′, reverse 5′-ACTTCAGGGAGTAAGAAGGAGG-
3′. Alkbh3 forward 5′-GAGCCAGTCTGCTACTCAGC-3′,
reverse 5′- AACACAAATTGTCGGTCACATTG-3′.
Results
Perinatal cochleae from Atoh1-GFP transgenic mice, cultured
and treated with gentamicin, show that gentamicin accumulated
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FIGURE 1 | Gentamicin-induced hair cell loss, and principal
component analysis (PCA) of RNA sequencing datasets. (A)
Gentamicin accumulates preferentially in hair cells in in vitro organ of Corti
culture. Cross sections through cochlear explants from P1, Atoh1-GFP mice
(Lumpkin et al., 2003), treated for 30min with Texas Red conjugated
gentamicin (GTTR). Star indicates the inner hair cell, and bracket indicates
three outer hair cells. Cells with weak GFP under the inner hair cell are inner
phalangeal cells. (B) Atoh1-GFP fluorescence in untreated and 0.5mM
gentamicin-treated organs at 3 and 24 h. There was no detectable hair cell
loss at 3 h, but severe hair cell damage caused by gentamicin at 24 h. Star
indicates a single row of inner hair cells and bracket indicates three partial
rows of outer hair cells. (C) Scatter plot of Atoh1-GFP hair cell purification by
FACS shows gate settings and diagram shows a P1 organ of Corti indicating
hair cells (green) and supporting cells (red) (Chen and Segil, 1999). (D) PCA
map showing the three most significant variances among samples. 78.88%
of variance in the combined dataset is captured in the analysis; (49.91% in
PC1-X axis, 13.53% in PC2-Y axis, and 8.44% on PC3-Z axis). Each dot
represents one biological replicate.
specifically in hair cells, as indicated by the uptake of Texas-
Red conjugated gentamicin (Figure 1A), and 91% (SD ± 7%;
n = 3) of outer hair cells were killed by gentamicin at 24 h
(Figure 1B). To investigate the early transcriptional response of
hair cells to gentamicin, cultured cochleae were treated with
gentamicin for 3 h, and immediately dissociated and FACS-
sorted to obtain purified hair cell and non-hair cell samples
(Figure 1C) for RNA sequencing. Since there is a low level of
misexpression of GFP in inner phalangeal cells and probably in
border cells, cells with low-level GFP expression were excluded
by stringently gating GFP during FACS purification to minimize
possible contamination. We validated the purity of the hair cell
population by immunostaining, as more than 95% of purified
GFP-positive cells stained positive for the hair cell markerMyoVI
(data not shown). In addition, known hair cell specific genes,
such as Atoh1, Pou4f3, Myo6, and Myo7a, have much greater
normalized read numbers in hair cell samples than that in
non-hair cell samples (Table S1), suggesting the high purity of
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our hair cell sample. The reliability of the RNA sequencing data
was verified by Q-PCR analysis with primers specific for selected
genes (Figures 2A, 3A, 4A, 5A, 6A).
Expression of 23420 genes was quantified and analyzed with
the Negative Binomial, Poisson or Lognormal Linear distribution
model (gene specific analysis algorithm provided by PartekFlow)
(Table S1). After 3 h of gentamicin treatment, the mRNA level of
3709 genes in hair cells was significantly altered, with 1917 genes
found to be up-regulated and 1792 genes down-regulated (p-
value < 0.01, fold change > 1.2 or <−1.2, and raw reads ≥100).
In contrast, significantly fewer genes (698) were found to be
affected with the same criteria in the non-hair cell population,
with 436 genes up-regulated and 262 genes down-regulated.
Principal Components Analysis
Principal components analysis (PCA) is a method for analyzing
the variance in high dimensional datasets, and to present variance
in a few dimensions for easier interpretation (Ringnér, 2008).
The PCA analysis of our RNA sequencing data shows that
71.88% variance in the dataset was captured within the three
most significant principal components (PCs): 49.91% in PC1
(X axis), 13.53% in PC2 (Y axis), and 8.44% in PC3 (Z axis)
(Figure 1D). These PCs correspond to different cell types and
different treatment conditions.
In the PCA map, each biological replicate of different
experimental groups is represented by one dot (Figure 1D).
PCA analysis indicates that the variance among the replicates
of FACS-purified hair cells is low. Three untreated hair cell
replicates cluster tightly in the PCA map (red dots), as do three
gentamicin-treated hair cell replicates (blue dots) (Figure 1D).
This tight clustering indicates low statistical variance between
replicates, and likely stems from the low cellular heterogeneity
among FACS-purified replicates. In contrast, both treated (green
dots) and untreated (yellow dots) samples from the non-hair cell
replicates, which include all other cells in our dissected epithelial
preparations, are scattered in the PCA map (Figure 1D),
indicating the higher statistical variance among replicates of the
non-hair cell samples. Hair cell samples and the non-hair cell
samples (Figure 1D, red vs. yellow) lie at the two ends of the
most significant variance axis (PC1, X axis), suggesting that the
hair cell gene expression profile is significantly different from the
non-hair cell population. Along the second variance axis (PC2,
Y axis), gentamicin-treated hair cell samples are separated from
untreated hair cell samples (Figure 1D, blue vs. red), indicating
the significant gene expression shift in hair cells caused by
gentamicin treatment at the 3 h time point. In contrast, the non-
hair cell samples are not separated by gentamicin treatment
(Figure 1D, green vs. yellow), suggesting that the gentamicin-
induced gene expression shift in the non-hair cell population
was not as consistent as the one in hair cells. Together, the PCA
results suggest that gentamicin treatment induced significant and
consistent gene expression changes in hair cells.
Signaling Pathways and Biological Processes
Affected by Gentamicin in Hair Cells
Gene expression in hair cells was affected significantly by
gentamicin treatment at 3 h, as shown by the large number
of deregulated genes and by the PCA results. To investigate
the underlying biological pathways affected in hair cells upon
gentamicin treatment, IPA software (Qiagen) was used to analyze
affected signaling pathways after gentamicin treatment, and to
compare our hair cell datasets with datasets derived from other
cell lines and tissues. Pathways affected by gentamicin treatment
at 3 h are listed in Table S2. Below we verify and discuss several
of these pathways that have been reported to be important in
aminoglycoside induced hair cell death, as well as proposing that
elements of the cell cycle may provide an additional pathway,
signaling apoptosis in hair cells.
Expression of JNK Pathway-Related Genes was
Significantly Affected by Gentamicin
The JNK pathway has been strongly implicated in
aminoglycoside-induced hair cell death. After aminoglycoside
treatment, phosphorylation of JNK and c-Jun was observed
in hair cells (Ylikoski et al., 2002), indicating activation of the
JNK pathway. Furthermore, inhibition of the JNK pathway
by pharmaceutical inhibitors has been shown to protect hair
cells from aminoglycoside ototoxicity (Ylikoski et al., 2002),
suggesting that JNK activation may be involved in mediating
aminoglycoside-induced hair cell death.
Consistent with these findings, we observed changes in the
expression of genes involved in JNK signaling pathways upon
gentamicin treatment. We verified the expression changes of
three genes in this pathway by Q-PCR, namely Atf2, Mapk8
(Jnk1), and Jun (c-Jun) (Figure 2A). IPA pathway analysis
revealed that the expression of JNK pathway-related genes was
significantly affected in gentamicin-treated hair cells (p =
0.000001). As shown in Figure 2B (color coded, see legend),
Mapk8 (Jnk1) itself, in addition to several upstream and
downstream factors including Jun, Atf2, Nfatc1, and Elk1, were
changed at the transcriptional level in gentamicin-treated hair
cells. Interestingly, the induction of Jun expression is regulated
by phosphorylation of Jun itself, in an autoregulatory loop, by
JNK (Angel et al., 1988); thus the increased mRNA expression
of Jun indicates the likely activation of the JNK pathway.
Transcriptional changes in other targets of Jun regulation are
summarized in Table S3. The pattern of changed expression
of JNK pathway-related genes is consistent with the timeline
of critical signaling events for aminoglycoside-induced hair
cell death, indicating that the JNK pathway is one of the
early response pathways that are activated in hair cells after
aminoglycoside treatment (Matsui et al., 2004).
Genes Involved in the NF-κB Pathway were
Expressed Differentially after Gentamicin Treatment
Activation of the NF-κB pathway has been implicated as
protective against aminoglycoside ototoxicity in several
biochemical assays (Jiang et al., 2005). Aminoglycoside treatment
has been shown to increase DNA binding activity of NF-κB,
indicating activation of the NF-κB pathway by aminoglycoside
antibiotics (Jiang et al., 2005). Additionally, reagents promoting
NF-κB translocation into nuclei reportedly protect hair cells
from aminoglycoside ototoxicity (Jiang et al., 2005).
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FIGURE 2 | Gentamicin-induced changes in expression of genes in the
Jun-kinase (JNK) pathway. (A) Q-PCR results validating increased
messenger RNA levels in hair cells after gentamicin treatment. Error bar,
standard deviation: *p < 0.05; **p < 0.01. (B) The JNK signaling pathway with
color-coded expression changes indicating significant transcriptional response
to gentamicin. Only genes with significant expression changes are colored.
Red, increased expression; green, decreased expression relative to control;
half red-half green, indicates nodes with multiple genes with some genes
upregulated and some genes downregulated. Genes validated and discussed
in the text are boxed in the corresponding protein pathway diagrams.
Our RNA sequencing data show that the expression of genes
involved in the NF-κB pathway was altered in hair cells after
gentamicin treatment. Gentamicin-induced expression changes
of Nfkb1 (p50), Nfkbib (Ikbb), and Chuk(Ikk1) were verified by
Q-PCR (Figure 3A). Fold changes based on RNA sequencing
were smaller but remained highly significant (p < 0.01). In
IPA pathway analysis, the NF-κB pathway was identified as a
significantly affected pathway in gentamicin-treated hair cells
(p = 0.00004). Expression changes of genes involved in the
NF-κB pathway are shown in Figure 3B. Among these genes,
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FIGURE 3 | Gentamicin-induced changes in expression of genes
in the NF-κB pathway. (A) Q-PCR results validating increased
messenger RNA levels in hair cells after gentamicin treatment.
Error bar, standard deviation: *p < 0.05; **p < 0.01. (B) NF-κB
pathway with color-coded expression changes suggesting early
transcriptional response to gentamicin. Only genes with significant
expression changes are colored. Red, increased expression; green,
decreased expression relative to control; half red-half green,
symbols for nodes consisting of multiple genes with some genes
upregulated and some genes downregulated. Genes validated and
discussed in the text are boxed in the corresponding protein
pathway diagrams.
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FIGURE 4 | Gentamicin-induced changes in expression of
stress-response genes. (A) Q-PCR results validating increased messenger
RNA levels in hair cells after gentamicin treatment. Error bar, standard
deviation: *p < 0.1; **p < 0.01. (B) NRF2-mediated oxidative stress response
network with color-coded expression shifts showing the absence of
significant induction of oxidative stress response at the transcriptional level.
Only genes with significant expression changes are color labeled. Red,
increased expression; green, decreased expression relative to control; half
red-half green, indicates nodes with multiple genes with some genes
upregulated and some genes downregulated. Genes validated and
discussed in the text are boxed in the corresponding protein pathway
diagrams.
Nfkb1 and Nfkbib have been identified as target genes of NF-κB
(Ten et al., 1992; Schreiber et al., 2006), and their increased
expression strongly suggests the activation of the NF-κB pathway
in gentamicin-treated hair cells. Transcriptional changes in other
NF-κB targets are summarized in Table S3. Our expression
data indicate that the NF-κB pathway, like the JNK pathway,
is an early response pathway that is activated in hair cells by
aminoglycosides.
Frontiers in Cellular Neuroscience | www.frontiersin.org 8 May 2015 | Volume 9 | Article 190
Tao and Segil RNAseq of hair cell ototoxicity
FIGURE 5 | Gentamicin-induced changes in expression of genes
involved in apoptosis. (A) Q-PCR results validating increased
messenger RNA levels in hair cells after gentamicin treatment. Error bar,
standard deviation: *p < 0.05; **p < 0.01. (B) The apoptosis gene network
with color-coded expression changes showing the absence of significant
changes for apoptosis initiation and execution genes at transcriptional
level. Only genes with significant expression changes are colored. Red,
increased expression; green, decreased expression relative to control; half
red-half green, indicates nodes with multiple genes with some genes
upregulated and some genes downregulated. Genes validated and
discussed in the text are boxed in the corresponding protein pathway
diagrams.
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FIGURE 6 | Gentamicin-induced changes in expression of genes
involved in cell cycle and DNA damage repair. (A) Q-PCR results
validating increased messenger RNA levels of selected genes in hair cells after
gentamicin treatment. These results confirm the up-regulation of cell cycle
and DNA damage repair genes in gentamicin-treated hair cells. Error bar,
standard deviation: *p < 0.05; **p < 0.01. (B) Cell cycle regulation network
with color-coded expression changes suggesting affected cell cycle gene
regulation by gentamicin. (C) Nucleotide excision repair (NER) network with
color-coded expression changes showing significant induction of NER genes.
Only genes with significant expression changes are colored. Red, increased
expression; green, decreased expression relative to control; half red-half
green, indicates nodes with multiple genes with some genes upregulated and
some genes downregulated. Genes validated and discussed in the text are
boxed in the corresponding protein pathway diagrams.
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No Significant Stress Response was Observed at the
Transcriptional Level for NRF2 Target Genes at the
3 h Time Point
The prevailing hypothesis of aminoglycoside ototoxicity holds
that aminoglycoside-induced ROS production causes oxidative
stress, which triggers apoptosis in hair cells. Cellular ROS levels
are reported to increase within minutes of aminoglycoside
administration in vitro (Hirose et al., 1997), and antioxidant
reagents are shown to protect hair cells from aminoglyocside
ototoxicity (Schacht, 1999). In addition, the oxidative stress
response mediated by the transcription factor NRF2 (Nfe2l2)
has been implicated in aminoglycoside ototoxicity (Hoshino
et al., 2011). Therefore, a response to oxidative stress at
the transcriptional level was expected. Surprisingly, although
some genes upstream of the Nrf2-dependent oxidative stress
pathway were upregulated in response to gentamicin at 3 h, the
transcriptional key regulator Nrf2 (Nfe2l2), was not affected,
nor were its well-studied transcriptional targets (Ma, 2013)
(Figure 4B and Table S3). We interpret this to mean that at this
early time point, the Nrf2 oxidative stress pathway has not been
fully activated. One explanation for this might be that at the
3 h time point, aminoglycoside-induced ROS production had not
increased to a level sufficient to overwhelm the highly-developed
antioxidant system in hair cells, and this hypothesis is supported
by the observation that after the initial disruption, a new balanced
redox state indicated by stable NAD(P)H fluorescence is reached
within 15min post-gentamicin treatment (Schafer and Buettner,
2001; Tiede et al., 2009). Alternatively, the catastrophic oxidative
stress may be caused by temporally downstream events such as
mitochondrial dysfunction.
Another group of genes, which drew our attention because of
a lack of early response, were those encoding heat shock proteins.
Expression of these genes was not induced by gentamicin at 3 h,
including the HspA group (Hspa1a, Hspa1b, Hspa5, and others),
the HspB group (Hspb1, Hspb2, and others), the HspC group
(Hsp90aa1, Hsp90ab1, and Hsp90b1), and other members in the
HspD, HspE, and HspG groups (Table S1). Among Dnaj family
members, which are involved in oxidative stress response, only
Dnaja2,Dnajb4, and someDnajc genes were expressed at slightly
higher levels (Table S1). The absence of strong induction of heat
shock protein genes suggests that hair cells had not launched a
broad stress response at 3 h, and indicates that transcriptional
changes in signaling pathways, such as the JNK and the NF-
κB pathways, at this time point were not simply caused by
dysregulation of general transcription under stress conditions.
Genes Involved in the Initiation and Execution of
Apoptosis were not Significantly Affected at the Early
Time Point
Aminoglycoside antibiotics are thought to induce hair cell death
through an intrinsic mitochondrial apoptosis pathway (Forge
and Li, 2000). Apoptosis is an active process that requires gene
transcription and protein synthesis (Matsui et al., 2002). In
contrast to genes involved in upstream pathways, such as the
JNK and the NF-κB pathways, which regulate apoptosis and
survival, genes involved in apoptosis initiation and execution
were not significantly affected in gentamicin-treated hair cells
at 3 h post treatment (Figure 5B). Although we observed up-
regulation of Casp3 expression and down-regulation of Casp2
and Casp9 expression, the majority of intrinsic mitochondrial
apoptosis pathway-related genes remained unchanged, including
pro- and anti-apoptosis Bcl2 family members (Figure 5B). The
lack of significant induction of apoptosis factors at this relatively
early time point is consistent with the critical events timeline of
aminoglycoside-induced hair cell death (Matsui et al., 2004). We
verified the expression changes of Bnip1, Casp3 and Ccar1 by
Q-PCR (Figure 5A).
We analyzed the cell-type specific response by comparing
gentamicin-induced expression changes in hair cells, with gene
expression changes during cell death in fibroblasts, neurons, and
kidneys (based on published literature as curated in the IPA data
base). Like hair cells, neurons are terminally-differentiated, non-
dividing cells, but pathways regulating neuronal cell apoptosis
are well characterized. We also emphasized the kidney because
nephrotoxicity is another well-known sequela to aminoglycoside
antibiotics treatment. These comparisons in IPA revealed that
gentamicin-induced gene expression changes in hair cells are
significantly different from the dataset derived from fibroblasts
(p = 0.0000927 and activation z-score −1.81) (activation z-
score is a quantitative measure of how similar the hair cell
dataset is to the “comparing dataset”: larger positive number
indicates there are more genes with expression changes in the
same direction in both datasets, while larger negative number
means there are more genes with changes in opposite direction
between datasets; see Table 1 caption), but similar to datasets of
neuronal cell death (p = 0.000280 and activation z-score 0.312),
and cell death of kidney cells (p = 0.00576 and activation z-score
0.664). The observed similarity between aminoglycoside-induced
hair cell death and neuronal cell death is not surprising, as hair
cells and neurons are related types of terminally differentiated,
excitable cells. The similarity between hair cells and kidney cells
in response to aminoglycoside-induced stress will be discussed
in Section: “Similarity between aminoglycoside ototoxicity and
nephrotoxicity” found below.
Gentamicin-Induced Changes in Cell Cycle and DNA
Damage Repair Genes Indicate Disruption of the
Postmitotic State
Another group of early response genes whose expression was
significantly affected upon exposure to gentamicin includes those
involved in cell cycle regulation and DNA damage repair. We
verified several genes in this group, including Ccnb2 (Cyclin
B2), Ccne2 (Cyclin E2), Ercc8 (Csa), Rad52, Apex2, and Alkbh3
(Figure 6A). Expression changes of genes involved in cell
cycle regulation and nucleotide excision repair are shown in
Figures 6B,C, respectively. Comparisons between gentamicin-
induced gene expression changes and known transcription
regulation of related genes during cell cycle or DNA damage
repair are summarized in Tables 2, 3, respectively. These
data suggest that the postmitotic state of hair cells was
disrupted following gentamicin treatment. Loss of control of
the postmitotic state and re-entry into the cell cycle preceding
neuronal cell apoptosis has been observed (Arendt, 2000), and
inhibition of cell cycle re-entry by blocking CDK activity has
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TABLE 1 | Comparison of the hair cell dataset with known expression
changes during cell death in other tissues and cell types.
Comparing dataset p-value Activation
z-score
# Genes
Cell death of kidney cells 5.76E-03 0.664 73
Cell death of kidney cell lines 1.09E-03 0.579 67
Neuronal cell death 2.80E-04 0.312 149
Cell death of brain cells 4.10E-04 0.024 63
Cell death of central nervous system cells 6.80E-04 0.015 66
Cell death of fibroblast cell lines 2.71E-04 −0.539 98
Cell death of cerebellar cortex cells 2.77E-05 −0.574 17
Cell death of tumor cell lines 4.70E-06 −0.656 331
Cell death of lymphoma cell lines 2.54E-03 −1.148 46
Cell death of fibroblasts 9.27E-05 −1.81 61
Selected entries are shown. The p-value, which is calculated using the right-tailed Fisher
Exact Test by IPA, is a measure of the likelihood that the association between a set of
focus genes in two datasets is due to random chance. Activation z-score is a quantitative
measure of how similar the hair cell dataset is to the “comparing dataset”: larger positive
number indicates there are more genes with expression changes in the same direction in
both datasets, while larger negative number means there are more genes with changes
in opposite direction between datasets. # Genes indicates number of overlapping genes
in the comparison.
TABLE 2 | Comparison of the hair cell dataset with known expression
changes in datasets from different stages of cell cycle.
Comparing dataset p-value Activation
z-score
# Genes
G2 phase 1.08E-06 0.964 69
G2/M phase 1.31E-03 0.507 46
Cell cycle progression 3.96E-07 0.199 237
Mitosis 2.51E-05 −0.075 112
G1 phase 6.42E-04 −0.401 86
G1/S phase transition 1.75E-03 −0.506 46
M phase 2.37E-04 −0.891 55
S phase 1.44E-04 −1.122 63
Interphase 9.91E-08 −1.334 160
Entry into interphase 4.35E-03 −1.523 35
Selected entries are shown.
been shown to protect neurons from apoptosis induced by certain
drugs or stress (Kruman, 2004; Golsteyn, 2005). Consistent with
these observations in neuronal cells, aberrant cell cycle re-entry,
induced by knocking out Cdkn1a (p21) and Cdkn2d (p19),
leads to hair cell apoptosis (Laine et al., 2007). Inhibition of
CDK2 activity also protects hair cells from gentamicin ototoxicity
(Tao and Segil, unpublished data), suggesting that the cell cycle
machinery plays a role in mediating hair cell death. Our RNA
sequencing data showing transcriptional changes to cell cycle-
related genes indicate a disruption of the postmitotic state, which
supports the idea that loss of cell cycle control may underlie an
additional pathway leading to hair cell death after gentamicin
treatment.
Induction of DNA damage repair genes also supports the
hypothesis that the postmitotic state is disrupted in hair cells
after gentamicin treatment. It is plausible that the induction
TABLE 3 | Comparison of the hair cell dataset with known expression
changes in genes associated with the DNA repair process.
Comparing dataset p-value Activation z-score # Genes
Repair of DNA 7.05E-06 1.953 66
DNA damage response of cells 6.09E-05 0.343 43
DNA replication 7.48E-05 −0.523 61
Metabolism of DNA 6.37E-04 0.357 90
Excision repair 1.02E-03 2.756 20
of DNA repair genes by DNA damage is caused by elevated
ROS levels after gentamicin treatment, but our experimental
observations do not support this explanation. First, the absence of
significant induction of oxidative stress response genes suggests
that the ROS production had not reached a level sufficient to
induce the change in known response genes. Second, we failed to
detect DNA damage by immunostaining against phosphorylated
Chk, or by comet assay (Tao and Segil, unpublished data).
Third, we did not observe induction of DNA damage repair
genes at the transcriptional level after treating the cochlea
with the DNA-damaging agent cisplatin (Ng, Rainey and Segil,
unpublished data). Based on these observations, we postulate
that up-regulated expression of DNA damage repair genes is
not triggered by gentamicin-induced DNA damage and ROS
production, but rather is more likely to reflect a change in cell
cycle status following gentamicin treatment.
Gene Expression Changes Induced by
Gentamicin in the Non-Hair Cell Population
Hair cells are specifically marked by GFP in Atoh1-GFP
transgenic mice (Figure 1A), thus the GFP negative population
consists of supporting cells (Deiters’ cells, pillar cells and
Hensen cells), cells in the greater epithelial ridge, cells in the
lesser epithelial ridge, and other cells constituting surrounding
tissues (inner phalangeal cells were excluded by FACS, based
on their low-level misexpression of GFP, Figures 1A,C). The
number of genes whose expression was affected by gentamicin
in non-hair cell samples is much smaller than that in hair
cells. The PCA results (Figure 1D) also show that the non-
hair cell population does not respond to gentamicin uniformly,
probably as a result of high heterogeneity. Expression of genes
involved in cholesterol synthesis, lipid synthesis, nucleotide
metabolism, and other biosynthesis processes, was significantly
induced after gentamicin treatment in this population (Table 4).
In addition, expression of genes involved in DNA replication and
cell cycle was significantly affected (Table 4). The gentamicin-
induced gene expression pattern of the non-hair cell population
suggests gentamicin-stimulated biosynthesis, and induced cell
proliferation in this population.
In the presence of Texas-Red conjugated gentamicin (GTTR)
in culture medium, hair cells had much higher GTTR
fluorescence than other cell types (Figure 1A), suggesting that
gentamicin preferentially accumulates in hair cells. However,
hair cells and supporting cells form a mosaic linked by tight
epithelial junctions and other cell-cell contacts (Gulley and Resse,
1976). Communication between hair cells and supporting cells
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TABLE 4 | Comparison of non-hair cell dataset with known expression
changes in biosynthesis and proliferation datasets.
Comparing dataset p-value Activation
z-score
# Genes
Synthesis of sterol 4.76E-11 1.723 16
Synthesis of cholesterol 1.04E-10 1.937 14
Metabolism of cholesterol 3.01E-10 1.937 17
Steroid metabolism 1.38E-05 1.937 20
Steroidogenesis 2.79E-05 1.929 17
Synthesis of terpenoid 3.74E-05 2.075 20
Metabolism of terpenoid 5.42E-05 1.937 21
Metabolism of membrane lipid derivative 6.59E-05 1.66 25
Conversion of acyl-coenzyme A 9.34E-05 1.964 4
Proliferation of cells 3.80E-03 2.161 136
Selected entries are shown.
is continuous as a result of cell-cell contact, and changes in one
cell type that result from the gentamicin treatment likely effect
physiological change in the other. One such cell-cell signaling
pathway significantly affected by gentamicin treatment in non-
hair cells is the Notch signaling pathway. Dll1 and Jag2 are
highly expressed as Notch ligands in hair cells, and Hes1, Hes5,
Hey1, and Hey2 are expressed in supporting cells as Notch
target genes (Zine and de Ribaupierre, 2002; Doetzlhofer et
al., 2009); after gentamicin treatment, expression of Dll1 and
Jag2 were down-regulated in hair cells, and Hes1, Hes5, Hey1,
and Hey2 were also expressed at a lower level in the non-hair
cell population (p = n.s. for Hes and Hey genes) (Table S1),
indicating disrupted cell-cell signaling between hair cells and
supporting cells. This observation supports the idea that the
expression profile changes that we observe in the non-hair
cell population may be brought about by changes in response
to gentamicin in hair cells. However, we could not exclude
the possibility that non-supporting cells in the GFP-negative
populationmight be responding to gentamicin treatment directly
at the transcriptional level.
Similarity between Aminoglycoside Ototoxicity
and Nephrotoxicity
Nephrotoxicity is another side effect of aminoglycoside
antibiotics, and several publications catalog the changes in
response to aminoglycoside antibiotics (Oh et al., 2006; Ozaki
et al., 2010). A statistical comparison of gentamicin-induced
hair cell gene expression changes and transcriptional profiles
after gentamicin treatment in kidney identified a significant
overlap between gene expression changes in gentamicin-treated
hair cells and kidneys (p = 8.02E-08). In the dataset obtained
from kidney, 211 genes were identified by microarray that were
significantly changed after gentamicin treatment (Ozaki et al.,
2010), and there were 50 genes in our hair cell dataset that
were changed in the same direction as they were in kidney
(Table 5).
We further compared the underlying biological processes
and pathways that were affected by gentamicin in kidney
and in hair cells, based on the transcriptional changes. We
observed similar changes in the expression of genes involved
in ribosome biogenesis, RNA processing, and translation in
gentamicin-treated kidney and hair cells (Table 5). In addition,
up-regulation of expression at the Jun gene, and induction of
DNA repair gene Lig4 were observed in both hair cells and
kidney. The similarity in transcriptional response to gentamicin
between hair cells and kidney cells suggests that there may
be some common mechanisms responsible for aminoglycoside
ototoxicity and nephrotoxicity, such as translation inhibition.
Despite the aforementioned similarity, the expression of stress
response genes differed greatly in gentamicin-treated kidney and
hair cells. Expression of oxidative stress response genes and Hsp
chaperone genes was collectively increased in gentamicin-treated
kidney while expression of these genes was not induced in hair
cells. The discrepancymight be based on the different time points
of sample collection (3 h post-gentamicin treatment for hair cell
sample vs. 7 days after treatment for kidney). It was difficult to
directly compare the expression of proliferation genes in kidneys
with that in hair cells, because the kidney is an organ consisting
of heterogeneous cell populations, with both dividing cells and
quiescent cells, whereas hair cells are postmitotic.
Discussion
The causes of hypersensitivity of hair cells to aminoglycoside
antibiotics remain unclear, and the prevailing hypothesis of
aminoglycoside ototoxicity holds that aminoglycosides induce
high levels of ROS leading to apoptotic stimulation. Our
purpose in this project was to characterize the hair cell
response to aminoglycoside antibiotics at an early time following
administration, before the changes associated with apoptosis
were apparent. To this end, we analyzed the response of hair
cells after 3 h of treatment with gentamicin. As indicated in
Figures 2, 3, the JNK pathway and the NF-κB pathway are
early responders, with many active components of the pathways
showing significant increases. In addition, early changes in cell
cycle-related genes, and DNA damage repair genes, signaled the
potential disruption of the postmitotic state. In contrast, genes
of the apoptosis and stress response pathways remain relatively
unchanged at this time point. The transcription profile of hair
cells at the early time point suggests that prior to the detection
of an ROS response at the transcriptional level, other changes
occur that may lead to the stimulation of apoptotic pathways,
such as the aforementioned JNK pathway, NF-κB pathway and
postmitotic state disruption.
Aminoglycoside-induced ROS production (Hirose et al.,
1997), the protective effect of antioxidants (Schacht, 1999), and
the NRF2-mediated oxidative stress response (Hoshino et al.,
2011), have all been implicated in aminoglycoside ototoxicity.
However, we did not observe a significant induction of the
transcriptional targets of NRF2 at 3 h in our in vitro system. In
addition, expression of heat shock chaperons and other stress
response genes were not significantly upregulated. These results
suggest that, although ROS changes in hair cells are rapid, at 3 h
after gentamicin treatment they have not reached a level sufficient
to trigger a broad stress response at the transcriptional level.
The catastrophic oxidative stress that triggers apoptosis might be
caused by continuous ROS build up, or by subsequent events such
as mitochondrial dysfunction.
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TABLE 5 | Comparison of gentamicin-induced hair cell gene expression changes with gentamicin-induced expression changes in kidney.
Gene symbol Function Annotation p-value in HC dataset Fold Change in HC dataset Findings in nephrotoxicity Consistent
Ppp1r10 Phosphatase 5.84E-06 4.524746 Upregulates Yes
Ddit3 Transcription factor 2.62E-05 2.751878 Upregulates Yes
Jun Transcription factor 0.00245 2.732988 Upregulates Yes
Ccnl1 RNA splicing 4.46E-06 2.482795 Upregulates Yes
Gnl3 p53 pathway regulation 7E-06 2.127794 Upregulates Yes
Chka Phospholipid synthesis 6.28E-07 2.029311 Upregulates Yes
Ddx39 RNA splicing 4.98E-06 1.991224 Upregulates Yes
Nop58 Ribosome biogenesis 7.68E-08 1.941254 Upregulates Yes
Ppp1r15a Phosphatase 0.009454 1.739694 Upregulates Yes
Kti12 Unkown 0.008232 1.649551 Upregulates Yes
Ptbp1 RNA splicing 3.83E-05 1.636352 Upregulates Yes
Eed Transcription repressor 8.35E-06 1.601639 Upregulates Yes
Eif2b2 Translation 3.21E-06 1.572336 Upregulates Yes
Cul2 Ubiquitin ligase 7.77E-06 1.510931 Upregulates Yes
Zfp622 Transcription regulator 4.77E-06 1.483148 Upregulates Yes
Naa15 N-acetyltransferase 0.000102 1.461136 Upregulates Yes
Smn1 RNA splicing 0.000161 1.45206 Upregulates Yes
Phax RNA export 0.006074 1.438425 Upregulates Yes
Lig4 DNA repair 5.82E-05 1.41918 Upregulates Yes
Azin1 Metabolism 0.001597 1.388636 Upregulates Yes
Arf6 Ras superfamily 0.000976 1.388019 Upregulates Yes
2310044G17Rik Unkown 0.005972 1.37605 Upregulates Yes
Eaf1 Transcription factor 0.000222 1.369313 Upregulates Yes
Cdk13 Transcription elongation 0.000244 1.365288 Upregulates Yes
Pafah1b1 Inactivates platelet-act. factor 0.000164 1.346669 Upregulates Yes
Gfer Growth factor 0.001933 1.324081 Upregulates Yes
Pelo Mitosis 0.000148 1.319478 Upregulates Yes
Tsc22d1 Transcription regulator 0.000157 1.315102 Upregulates Yes
Ddx50 RNA helicase 0.00147 1.313465 Upregulates Yes
Gadd45a MAPK pathway regulator 0.007003 1.30902 Upregulates Yes
Tars tRNA synthesis 0.001263 1.292011 Upregulates Yes
Mdm2 p53 pathway regulation 0.005424 1.28435 Upregulates Yes
Dnaja2 Chaperone 0.001429 1.282581 Upregulates Yes
Eif2b4 Translation 0.001361 1.270756 Upregulates Yes
Sfpq RNA splicing 0.000749 1.252767 Upregulates Yes
Cnksr3 Sodium transport 0.00051 1.240931 Upregulates Yes
Cand1 Ubiquitin ligase 0.003349 1.215329 Upregulates Yes
Mybbp1a Transcription regulator 0.000956 1.214954 Upregulates Yes
Ncl Ribosome biogenesis 0.00327 1.206809 Upregulates Yes
Decr2 Metabolism 0.003445 −1.21269 Downregulates Yes
Asl Urea cycle 0.000314 −1.27227 Downregulates Yes
Acsl3 Metabolism 0.000638 −1.27564 Downregulates Yes
Gstm1 Antioxidant 0.00249 −1.32453 Downregulates Yes
S100a1 Calcium binding 0.006299 −1.37041 Downregulates Yes
Abat Metabolism 0.002967 −1.38497 Downregulates Yes
Mrpl23 Mitochondrial ribosome 0.003565 −1.38508 Downregulates Yes
Hacl1 Metabolism 0.002033 −1.43919 Downregulates Yes
St6galnac3 Glycolipid synthesis 0.005244 −1.46649 Downregulates Yes
Pcx Metabolism 0.00279 −1.65712 Downregulates Yes
Eef1a1 Translation 2.35E-05 −2.0177 Downregulates Yes
Zfp354a Unkown 0.001648 1.544937 Downregulates No
(Continued)
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TABLE 5 | Continued
Gene symbol Function Annotation p-value in HC dataset Fold Change in HC dataset Findings in nephrotoxicity Consistent
Hyou1 Stress 0.002956 −1.22211 Upregulates No
Nedd4 Ubiquitin ligase 2.45E-06 −1.27335 Upregulates No
Ctsd Protease 0.00174 −1.33383 Upregulates No
Hspa5 Stress 0.004463 −1.3884 Upregulates No
Calr Calcium binding 0.000413 −1.4266 Upregulates No
Hsp90b1 Chaperone 5.87E-05 −1.56328 Upregulates No
Egr1 Transcription regulator 0.004467 −1.61013 Upregulates No
Zfp36l1 Growth factor response 0.001571 −1.65211 Upregulates No
Pdia4 Protein folding 0.002689 −1.72559 Upregulates No
Tubb5 Cytoskeleton 0.001836 −2.0123 Upregulates No
Spp1 Cell-matrix interaction 0.004118 −4.30391 Upregulates No
Expression of genes involved in initiation and execution
of apoptosis were not significantly induced at this early time
point, which is consistent with the established timeline of
hair cell apoptosis (Matsui et al., 2004), and in line with the
absence of a strong stress response at the transcriptional level.
Together, the data suggest that, at this relatively early time
point, hair cells are not yet committed to apoptosis. However,
we observed expression changes for genes in upstream signaling
pathways regulating apoptosis and cell survival. Not surprisingly,
comparison of the observed gentamicin-induced changes in hair
cells, with those from cell death studies in other cell lines or
tissues, revealed a significant similarity in response to stress.
The disruption of the postmitotic state of hair cells is indicated
by expression changes of cell cycle-related genes, suggesting
that postmitotic state disruption in dying hair cells is another
potential mechanism regulating apoptosis in hair cells, similar
to what has been reported in postmitiotic neurons. Cell cycle re-
entry has been observed in neurons before neuronal cell death,
especially in neurodegenerative diseases (Arendt, 2000). In the
central nervous system, mature neurons with mutated genes
involved in maintaining the postmitotic state (inactivation of
p19Ink4d and p27Kip1) lose control of the postmitotic state, re-
enter the cell cycle, and eventually undergo apoptosis (Zindy
et al., 1999). Activation of the cell cycle machinery is considered
one of the mechanisms controlling programmed cell death
in postmitotic neurons, either through direct regulation of
apoptosis pathways, or through checkpoint activation (Kruman,
2004; Golsteyn, 2005). In the cochlea, aberrant cell cycle re-
entry leads to hair cell apoptosis (Chen et al., 2003; Laine
et al., 2007). Inhibition of CDK activity by pharmaceutical
inhibitors or genetic mutations of CDK genes protect hair cells
from aminoglycoside ototoxicity (Tao and Segil, unpublished
data), suggesting that cell cycle machinery regulates hair cell
death. This mechanism is also supported by our expression data.
Genes involved in cell cycle progression, G2 phase, and G2/M
were significantly affected at the transcriptional level (Table 2),
indicating a disruption of the quiescent state of hair cells by
gentamicin treatment.
Further evidence supporting the loss of cell cycle control
mechanisms includes our observation that hair cells up-regulate
the expression of DNA repair genes after gentamicin treatment.
Although induction of DNA repair genes by gentamicin-induced
DNA damage is a plausible explanation, the lack of strong
oxidative stress response at the transcriptional level, failure of
DNA damage detection in hair cells after gentamicin treatment
(Tao and Segil, unpublished data), and unchanged DNA repair
gene expression at the transcriptional level in hair cells after DNA
damaging agent treatment (Ng, Rainey and Segil, unpublished
data) together suggest that gentamicin-induced DNA repair
gene expression is not responding to DNA damage, but may
be responding to a form of “replicative stress” induced by the
disruption of the postmitotic state, similar to that observed in
neurons exiting the postmitotic state (Andrusiak et al., 2012).
During final differentiation and withdrawal from cell cycle, many
postmitotic cells, such as neurons, which need never replicate
their genomes again and thus can resort to repairing only
essential genes, down-regulate global genomic DNA repair and
rely entirely on transcription-coupled repair to maintain actively
transcribed genes (Nouspikel and Hanawalt, 2000). Based on
the observation that hair cell homeostasis requires transcription-
coupled repair for long-term survival (Nagtegaal et al., 2015), we
postulate that DNA repair capacity is regulated during hair cell
differentiation and cell cycle withdrawal. Thus, up-regulation of
the expression of DNA repair genes may indicate disruption of
the quiescent state and cell cycle control.
Taken together, our RNA sequencing data suggests that at 3 h,
an early time point after gentamicin treatment, activation of the
JNK and NF-κB signaling pathways and the disruption of the
quiescent state, indicated by significant transcription changes,
precede broad stress response and apoptosis initiation, and that
these early responses may regulate aminoglycoside-induced hair
cell death.
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